Compare Amgen, Inc. (AMGN) vs Intel Corp (INTC) Price & Performance

Amgen, Inc.Trade

Intel CorpTrade

Price performance (Past 24H)

Key statistics

Amgen, Inc. vs Intel Corp — how do they compare? Amgen, Inc. trades at $412.21 (market cap $224.14B), while Intel Corp trades at $99.03 (market cap $492.85B). The key difference: Intel Corp is far larger — about 2.2× Amgen, Inc.'s market cap, and Amgen, Inc. pays the higher dividend (2.43%). Which is the better fit depends on your goals.

	AMGN	INTC
Market Cap	$224.14B	$492.85B
Sector	Health	Technology
52-Week High	$417.20	$140.94
52-Week Low	$271.18	$21.81
Enterprise Value	$267.45B	$513.66B
Dividend Yield	2.43%	2.24%
Volume	—	43,552,012

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMGN

BioCryst hits profitability with strong Q2 revenue, sparking takeover interest in rare disease biotech.24/7 Wall Street · 1 day agoBullish View details →

INTC

Polen 5Perspectives Large Growth Portfolio outperforms Russell 1000 Growth with 26.63% return in Q2 2026Seeking Alpha · 14 hours agoBullish Intel stock upgraded to Buy as Q2 revenue jumps 25%, margins expand, and outlook beats expectations.Seeking Alpha · 1 day agoBullish Intel stock soars 370% in a year, fueled by Nvidia partnership and AI demand.Finbold · 1 day agoBullish View details →

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

About Intel Corp

Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.